Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ceulemans

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Obstetrics and Gynecology|June 4, 2025
Pharmacological treatment of hypertension in pregnancy: one does not fit all hemodynamic subtypesMichael Ceulemans, Wilfried Gyselaers
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 4, 2020
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic: A call for actionMichael Ceulemans, Titia Hompes, Veerle Foulon
JAMA Psychiatry|January 10, 2024
SSRIs in Pregnancy-What Offspring Brain Volumes Can and Cannot Tell UsMichael Ceulemans, Per Damkier, Alice Panchaud
European Journal of Clinical Pharmacology|July 27, 2021
Maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the sceneryKarel Allegaert, Michael Ceulemans, John van den Anker
JACC. Advances|January 18, 2026
Targeted Therapy for Hypertension in Pregnancy: Hemodynamics as a Therapeutic CompassMichael Ceulemans, Ruben Heremans, Chahinda Ghossein, et al.
British Journal of Clinical Pharmacology|September 19, 2025
Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systemsHülya Tezel Yalçın, Nadir Yalçın, Michael Ceulemans, et al.
International Journal of Environmental Research and Public Health|April 12, 2022
Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative AnalysisLaure Sillis, Veerle Foulon, Jan Y Verbakel, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed<sup>®</sup>Hülya Tezel Yalçın, Nadir Yalçın, Michael Ceulemans, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare ProfessionalsMichael Ceulemans, Kristel Van Calsteren, Karel Allegaert, et al.
Pharmacoepidemiology and Drug Safety|July 26, 2019
Health products' and substance use among pregnant women visiting a tertiary hospital in Belgium: A cross-sectional studyMichael Ceulemans, Kristel Van Calsteren, Karel Allegaert, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Obstetrics and Gynecology|June 4, 2025
Pharmacological treatment of hypertension in pregnancy: one does not fit all hemodynamic subtypesMichael Ceulemans, Wilfried Gyselaers
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 4, 2020
Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic: A call for actionMichael Ceulemans, Titia Hompes, Veerle Foulon
JAMA Psychiatry|January 10, 2024
SSRIs in Pregnancy-What Offspring Brain Volumes Can and Cannot Tell UsMichael Ceulemans, Per Damkier, Alice Panchaud
European Journal of Clinical Pharmacology|July 27, 2021
Maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the sceneryKarel Allegaert, Michael Ceulemans, John van den Anker
JACC. Advances|January 18, 2026
Targeted Therapy for Hypertension in Pregnancy: Hemodynamics as a Therapeutic CompassMichael Ceulemans, Ruben Heremans, Chahinda Ghossein, et al.
British Journal of Clinical Pharmacology|September 19, 2025
Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systemsHülya Tezel Yalçın, Nadir Yalçın, Michael Ceulemans, et al.
International Journal of Environmental Research and Public Health|April 12, 2022
Experiences and Perspectives of Marketing Authorisation Holders towards Medication Safety Monitoring during Pregnancy: A Pan-European Qualitative AnalysisLaure Sillis, Veerle Foulon, Jan Y Verbakel, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed<sup>®</sup>Hülya Tezel Yalçın, Nadir Yalçın, Michael Ceulemans, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare ProfessionalsMichael Ceulemans, Kristel Van Calsteren, Karel Allegaert, et al.
Pharmacoepidemiology and Drug Safety|July 26, 2019
Health products' and substance use among pregnant women visiting a tertiary hospital in Belgium: A cross-sectional studyMichael Ceulemans, Kristel Van Calsteren, Karel Allegaert, et al.
Pageof 7